TCD Scientists Make Significant Type 2 Diabetes Breakthrough - Scientists at Trinity College Dublin have discovered what could be the underlying basis for Type 2 diabetes, they found that the peptide hormone, Islet Amyloid Polypeptide (IAPP), which gets deposited in the pancreas in Type 2 diabetes, is the trigger for a protein complex called the inflammasome.
http://insciences.org/article.php?article_id=9502
Pilot Study Demonstrates Safety of Diabetes Medication for Patients With Alzheimer's — A pilot study suggests the diabetes medication pioglitazone is generally well tolerated and may warrant further study as a treatment for patients with Alzheimer's disease, according to a report posted online that will appear in the January 2011 print issue of Archives of Neurology, one of the JAMA/Archives journals.
http://www.sciencedaily.com/releases/2010/09/100913162336.htm
BD, Sanofi Team To Deliver Flu Vaccine With Tiny, Painless Needle
http://www.topdevicecompanies.com/2...r-flu-vaccine-with-tiny-painless-needle-.html
Experimental Diabetes Drug Taspoglutide Late-Stage Trials Suspended - Experimental diabetes drug, taspoglutide, a joint development between Roche (Switzerland) and Ipsen (France), had its late-stage trials suspended because of because of adverse gastrointestinal reaction side effects.
http://www.medilexicon.com/medicalnews.php?newsid=200893
Injectable diabetes drug approved - Victoza (liraglutide), which has been given the approval by NICE, will help people stabilise their blood sugar levels and provide an alternative to tablets and insulin.
http://www.nursinginpractice.com/de...pproved&page=article.display&article.id=22991
Sanofi discontinuing old insulin pens in UK - Discontinuing use of the old insulin pens will leave Sanofi with two delivery options for its insulin products; Sanofi's move is in response to June guidance from the UK National Patient Safety Agency (NPSA) which aims to make administration of insulin safer.
http://www.in-pharmatechnologist.co...d-insulin-pens-in-UK?utm_source=RSS_text_news
NICE recommends liraglutide for type 2 - In draft guidance, NICE recommends liraglutide[[1]] (Victoza, Novo Nordisk) 1.2 mg daily for some people with type 2 but does not recommend liraglutide at 1.8mg daily, as the evidence suggests no significant additional benefit with the higher dose.
http://www.nice.org.uk/newsroom/pressreleases/NICERecommendsLiraglutideForType2DiabetesMellitus.jsp
AstraZeneca joins UCL to find stem cell cure for diabetic blindness - AstraZeneca and University College London (UCL) have a research partnership to develop medicines that use stem cells to repair damaged eyesight in people with diabetes.
http://www.guardian.co.uk/business/2010/sep/12/astrazeneca-ucl-stem-cells-diabetes-blindness
Got statins? UF cardiologists recommend new use for old drug
http://news.ufl.edu/2010/09/16/statins/
http://insciences.org/article.php?article_id=9502
Pilot Study Demonstrates Safety of Diabetes Medication for Patients With Alzheimer's — A pilot study suggests the diabetes medication pioglitazone is generally well tolerated and may warrant further study as a treatment for patients with Alzheimer's disease, according to a report posted online that will appear in the January 2011 print issue of Archives of Neurology, one of the JAMA/Archives journals.
http://www.sciencedaily.com/releases/2010/09/100913162336.htm
BD, Sanofi Team To Deliver Flu Vaccine With Tiny, Painless Needle
http://www.topdevicecompanies.com/2...r-flu-vaccine-with-tiny-painless-needle-.html
Experimental Diabetes Drug Taspoglutide Late-Stage Trials Suspended - Experimental diabetes drug, taspoglutide, a joint development between Roche (Switzerland) and Ipsen (France), had its late-stage trials suspended because of because of adverse gastrointestinal reaction side effects.
http://www.medilexicon.com/medicalnews.php?newsid=200893
Injectable diabetes drug approved - Victoza (liraglutide), which has been given the approval by NICE, will help people stabilise their blood sugar levels and provide an alternative to tablets and insulin.
http://www.nursinginpractice.com/de...pproved&page=article.display&article.id=22991
Sanofi discontinuing old insulin pens in UK - Discontinuing use of the old insulin pens will leave Sanofi with two delivery options for its insulin products; Sanofi's move is in response to June guidance from the UK National Patient Safety Agency (NPSA) which aims to make administration of insulin safer.
http://www.in-pharmatechnologist.co...d-insulin-pens-in-UK?utm_source=RSS_text_news
NICE recommends liraglutide for type 2 - In draft guidance, NICE recommends liraglutide[[1]] (Victoza, Novo Nordisk) 1.2 mg daily for some people with type 2 but does not recommend liraglutide at 1.8mg daily, as the evidence suggests no significant additional benefit with the higher dose.
http://www.nice.org.uk/newsroom/pressreleases/NICERecommendsLiraglutideForType2DiabetesMellitus.jsp
AstraZeneca joins UCL to find stem cell cure for diabetic blindness - AstraZeneca and University College London (UCL) have a research partnership to develop medicines that use stem cells to repair damaged eyesight in people with diabetes.
http://www.guardian.co.uk/business/2010/sep/12/astrazeneca-ucl-stem-cells-diabetes-blindness
Got statins? UF cardiologists recommend new use for old drug
http://news.ufl.edu/2010/09/16/statins/
